Resistance Testing to Improve Management of Virologic Failure in Sub-Saharan Africa

NACompletedINTERVENTIONAL
Enrollment

840

Participants

Timeline

Start Date

December 8, 2016

Primary Completion Date

September 8, 2020

Study Completion Date

September 8, 2020

Conditions
HIVAIDS
Interventions
PROCEDURE

HIV-1 RNA Resistance Testing

Perform drug resistance on enrollment to guide management of virologic failure

Trial Locations (2)

Unknown

University of Kwa-Zulu Natal, Durban

Mbarara University of Science and Technology, Mbarara

All Listed Sponsors
collaborator

Mbarara University of Science and Technology

OTHER

collaborator

University of KwaZulu

OTHER

collaborator

Emory University

OTHER

collaborator

University of Rochester

OTHER

collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Massachusetts General Hospital

OTHER

NCT02787499 - Resistance Testing to Improve Management of Virologic Failure in Sub-Saharan Africa | Biotech Hunter | Biotech Hunter